• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Resistance training not superior to neuromuscular exercises for hip osteoarthritis

byJunghoon KoandKiera Liblik
June 6, 2024
in Chronic Disease, Rheumatology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this randomized controlled trial, progressive resistance training (PRT) was not superior to neuromuscular exercise (NEMEX) in improving functional performance in patients with hip osteoarthritis (OA).

2. PRT was not superior to NEMEX in improving patients’ hip pain or hip-related quality of life.

Evidence Rating Level: 1 (Excellent)

Study Rundown: OA is a degenerative joint disease characterized by the breakdown of cartilage between bones, which results in pain, decreased range of motion, and impaired quality of life. Hip OA is one of the most common forms of OA, and its prevalence is expected to increase due to aging demographics. While exercise is recommended as the first-line treatment for hip OA, evidence for the optimal type and exercise regimen is currently lacking. NEMEX, which focuses on functional stability and postural control, has been implemented in several countries to treat patients with hip OA. However, there has been increasing evidence for the efficacy of PRT, whose role in increasing muscle mass, strength, and power may improve functional impairments exhibited by these patients. Thus, this study aimed to investigate whether a 12-week regimen of PRT was more effective than that of NEMEX in improving functional performance in those with hip OA. Secondary outcomes were also explored, including pain and hip-related quality of life. Overall, the trial demonstrated that PRT was not superior to NEMEX in improving function in patients with hip OA. It also showed that PRT was not superior to NEMEX in improving patients’ hip pain or hip-related quality of life. Both patients and physiotherapists were unable to be blinded to treatment allocation, subjecting the study to potential performance bias.

Click to read the study in AIM

In-Depth [randomized controlled trial]: This cluster-randomized, controlled trial aimed to compare the efficacy of PRT to NEMEX in improving the functional performance of patients with hip OA. Patients were eligible if they were 45 or older, had OA of one or both hips, and had hip pain during activity within the previous two weeks. Enrolled participants were randomly assigned via cluster randomization to undergo a 12-week regimen of two 60-minute sessions each week of PRT or NEMEX. PRT sessions consisted of 5 generic exercises targeting the muscles of the knee and hip joints. NEMEX sessions encompassed 10 exercises whose progression was based on varying the movements’ number, direction, and velocity. The primary outcome was a change in the 30-second chair stand test (30s-CST) from baseline to the 12-week follow-up. Key secondary outcomes included changes in the pain and hip-related quality of life subscales of the Hip Disability and Osteoarthritis Outcome Score (HOOS) at 12 weeks. Of 339 screened patients, 160 were randomly assigned to PRT (82) or NEMEX (78). The mean change in the 30s-CST scores was 1.5 chair stands (95% confidence interval [CI], 0.9 to 2.1) for the PRT group and 1.5 chair stands (95% CI, 0.9 to 2.1) for the NEMEX group, for a mean between-group difference of 0.0 chair stands (95% CI, -0.8 to 0.8). The mean change in the HOOS pain subscale was 8.6 points (95% CI, 5.3 to 11.8) with PRT and 9.3 points (95% CI, 5.9 to 12.6) with NEMEX (mean difference, -0.7 points; 95% CI, -5.3 to 4.0). Moreover, the mean change in the HOOS quality of life subscale was 8.0 points (95% CI, 4.3 to 11.7) with PRT and 5.7 points (95% CI, 1.9 to 9.5) with NEMEX (mean difference, 2.3 points; 95% CI, -3.0 to 7.6). In summary, this study demonstrated that PRT was not superior to NEMEX in improving functional performance, hip pain, or hip-related quality of life in patients with hip OA.

RELATED REPORTS

2 Minute Medicine Rewind Aug 24th, 2026 

Joint fusion superior to watchful waiting for hallux rigidus 

The addition of leflunomide (Arava) to prednisone (Deltasone) may not improve rate of remission in Takayasu arteritis

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic diseaseneuromuscular exerciseorthopedic surgeryosteoarthritisresistance trainingrheumatology
Previous Post

#VisualAbstract: Semaglutide Improves Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease

Next Post

Empagliflozin does not decrease risk of hospitalization or death after myocardial infarction

RelatedReports

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Weekly Rewinds

2 Minute Medicine Rewind Aug 24th, 2026 

August 26, 2026
Uninterrupted warfarin therapy safe for endovascular procedures
Orthopedic Surgery

Joint fusion superior to watchful waiting for hallux rigidus 

August 10, 2026
Lower target oxygen saturation in extremely preterm infants appears safe
Chronic Disease

The addition of leflunomide (Arava) to prednisone (Deltasone) may not improve rate of remission in Takayasu arteritis

July 10, 2026
Amyloid may cause distant cerebral hypometabolism in Alzheimer’s
Psychiatry

Glucosamine Linked to Faster Alzheimer’s Progression in Patients with Mild Cognitive Impairment

July 10, 2026
Next Post
Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

Empagliflozin does not decrease risk of hospitalization or death after myocardial infarction

No obesity paradox found between BMI, stroke, and death

Decompressive craniectomy may benefit patients with supratentorial intracerebral hemorrhage

Influenza vaccine not associated with increased risk of epilepsy in children

Corticosteroid injections not found to be associated with fracture risk in elderly cohort

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bundibugyo Ebola outbreak surpasses 5,700 cases without a validated vaccine
  • Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy
  • Looksmaxxing raises body dysmorphia concerns among adolescent males
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in